| Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets Á Nagy, A Lánczky, O Menyhárt, B Győrffy Scientific reports 8 (1), 9227, 2018 | 1288 | 2018 |
| Pancancer survival analysis of cancer hallmark genes Á Nagy, G Munkácsy, B Győrffy Scientific reports 11 (1), 6047, 2021 | 988 | 2021 |
| Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients AM Szász, A Lánczky, Á Nagy, S Förster, K Hark, JE Green, ... Oncotarget 7 (31), 49322, 2016 | 959 | 2016 |
| miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients A Lánczky, Á Nagy, G Bottai, G Munkácsy, A Szabó, L Santarpia, B Győrffy Breast cancer research and treatment 160, 439-446, 2016 | 768 | 2016 |
| Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma O Menyhárt, Á Nagy, B Győrffy Royal Society open science 5 (12), 181006, 2018 | 406 | 2018 |
| Different mutations in SARS-CoV-2 associate with severe and mild outcome Á Nagy, S Pongor, B Győrffy International journal of antimicrobial agents 57 (2), 106272, 2021 | 150 | 2021 |
| muTarget: a platform linking gene expression changes and mutation status in solid tumors Á Nagy, B Győrffy International journal of cancer 148 (2), 502-511, 2021 | 83 | 2021 |
| Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets Á Nagy, A Lánczky, O Menyhárt, B Győrffy Scientific reports 8, 2018 | 71 | 2018 |
| KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer Á Nagy, LS Pongor, A Szabó, M Santarpia, B Győrffy International journal of cancer 140 (4), 930-937, 2017 | 45 | 2017 |
| Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival Á Nagy, Á Ősz, J Budczies, S Krizsán, G Szombath, J Demeter, C Bödör, ... Journal of advanced research 20, 105-116, 2019 | 43 | 2019 |
| Genomic mapping identifies mutations in RYR2 and AHNAK as associated with favorable outcome in basal-like breast tumors expressing PD1/PD-L1 FJ Cimas, A Manzano, M Baliu-Piqué, E García-Gil, P Pérez-Segura, ... Cancers 12 (8), 2243, 2020 | 26 | 2020 |
| COVIDOUTCOME—estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome Á Nagy, B Ligeti, J Szebeni, S Pongor, B Győrffy Database 2021, baab020, 2021 | 24 | 2021 |
| Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers EC Morafraile, C Saiz-Ladera, C Nieto-Jiménez, B Győrffy, A Nagy, ... Current Oncology 30 (3), 2569-2581, 2023 | 3 | 2023 |
| Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer HL Pálinkás, L Pongor, M Balajti, Á Nagy, K Nagy, A Békési, G Bianchini, ... International Journal of Molecular Sciences 23 (2), 633, 2022 | 3 | 2022 |
| Internet-based opportunities in breast cancer diagnostics and research Á Nagy, B Gyõrffy Magyar onkologia 60 (4), 273-280, 2015 | 1 | 2015 |
| Környezetből származó mikrobiális nukleinsavminták vizsgálati lehetőségei IK Kerekes, Á Nagy, Á Ősz, P Zalka Orvosi Hetilap 165 (16), 613-619, 2024 | | 2024 |